Skip to main content
Livermore
Livermore
ZHEN

EagleClaw Capital Managment, LLC

SEC CIK
0001607636
Latest filing
Aug 10, 2026

PFE holding history

Pfizer Inc in every 13F filed by EagleClaw Capital Managment, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
153,401
Value
$3.69M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of PFE by EagleClaw Capital Managment, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026153,401$3.69M0.5%+42,358+38.1%AddedHolders
Q1 2026111,043$3.12M0.4%+82,275+286.0%AddedHolders
Q4 202528,768$716.3K0.1%+3,100+12.1%AddedHolders
Q3 202525,668$654.0K0.1%−750−2.8%ReducedHolders
Q2 202526,418$640.4K0.1%−863−3.2%ReducedHolders
Q1 202527,281$691.3K0.1%+100+0.4%AddedHolders
Q4 202427,181$721.1K0.1%−463−1.7%ReducedHolders
Q3 202427,644$800.0K0.1%−750−2.6%ReducedHolders
Q2 202428,394$794.5K0.1%00.0%UnchangedHolders
Q1 202428,394$787.9K0.1%+1,000+3.7%AddedHolders
Q4 202327,394$788.7K0.2%00.0%UnchangedHolders
Q3 202327,394$908.7K0.2%00.0%UnchangedHolders
Q2 202327,394$1.00M0.2%−2,015−6.9%ReducedHolders
Q1 202329,409$1.20M0.3%00.0%UnchangedHolders
Q4 202229,409$1.51M0.4%00.0%UnchangedHolders
Q3 202229,409$1.29M0.4%+1,401+5.0%AddedHolders
Q2 202228,008$1.47M0.4%−1,726−5.8%ReducedHolders
Q1 202229,734$1.54M0.4%−825−2.7%ReducedHolders
Q4 202130,559$1.80M0.4%+600+2.0%AddedHolders
Q3 202129,959$1.29M0.3%+625+2.1%AddedHolders
Q2 202129,334$1.15M0.3%00.0%UnchangedHolders
Q1 202129,334$1.06M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.